| Financial Year |
March 31 2023 |
| Monetary Funds |
406,744,478.20 |
| Held-for-trading Financial Assets |
540,024,129.61 |
| Notes Receivable |
4,926,715.64 |
| Accounts Receivable |
456,513,039.23 |
| Advances to Suppliers |
87,549,783.75 |
| Other Receivables |
16,627,830.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
682,961,858.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
9,583,133.68 |
| Other Current Assets |
51,622,424.93 |
| Total Current Assets |
2,256,732,850.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
16,364,692.10 |
| Fixed Assetes |
433,194,351.32 |
| Under-construction Projects |
294,517,475.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
95,015,224.36 |
| R&D expenses |
-- |
| Goodwill |
24,678,766.57 |
| Long-Term Deferred and Prepaid Expenses |
5,000,242.04 |
| Deferred Income Tax Assets |
20,650,108.58 |
| Other Non-Current Assets |
21,703,566.33 |
| Sub-Total of Non-Current Assets |
1,510,495,687.80 |
| Total Assets |
3,767,228,538.24 |
| Short-Term Loans |
50,100,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
204,497,104.28 |
| Accounts Received In Advance |
492,786.77 |
| Employee Compensation Payable |
1,237,328.23 |
| Taxes Payable |
23,425,000.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
26,870,486.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,246,560.99 |
| Other Current Liabilities |
2,169,769.39 |
| Sub-Total of Current Liabilities |
333,501,406.30 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
30,981,702.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
74,757,197.18 |
| Total Liabilities |
408,258,603.48 |
| Paid-In Capital(Or Share Stock) |
383,237,774.00 |
| Capital Surplus |
1,493,628,793.70 |
| Surplus Reserve |
170,288,921.22 |
| LESS:Treasury Stock |
78,598,741.10 |
| Undistributed Profits |
1,141,121,335.55 |
| Minority Stockholder's Interest |
249,913,226.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,109,056,707.85 |
| Owner's Equity（Stockholder's Equity） |
3,358,969,934.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,767,228,538.24 |
